Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

ETR/PHI1 stock hub

ETR/PHI1 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/PHI1is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

22B

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/PHI1

In the news

Latest news · ETR/PHI1

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E14.9

P25 12.3P50 15.7P75 20.2

Trailing P/E22.7

P25 16.4P50 20.9P75 30.4

ROE8.4

P25 -6.7P50 8.5P75 17.2

ROIC7

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/PHI1 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

226

Groups with data

Currency

EUR

Showing 226 of 226 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Netherlands
Country code	DE
Employees	64,317
Employees Change	-1,861%
Employees Change Percent	-2.79
Enterprise value	EUR 27.5B
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-05-10
Industry	Medical Devices
Isin	NL0000009538
Last refreshed	2026-05-10
Market cap	EUR 22B
Price	EUR 23.57
Price currency	EUR
Rev Per Employee	274,297.62x
Sector	Healthcare
Sic	3845
Symbol	etr/PHI1
Website	https://www.philips.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.41%
EV Earnings	28.39x
EV/EBIT	18.3x
EV/EBITDA	12.14x
EV/FCF	13.73x
EV/Sales	1.56x
FCF yield	9.11%
Forward P/E	14.91x
P/B ratio	1.93x
P/E ratio	22.69x
P/S ratio	1.25x
PE Ratio10 Y	31.67x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.6%
EBITDA Margin	11.85%
FCF margin	11.37%
Gross margin	45.2%
Gross Profit	EUR 8B
Gross Profit Growth	2.14%
Gross Profit Growth Q	-4.54%
Gross Profit Growth3 Y	2.34%
Gross Profit Growth5 Y	-1.54%
Net Income	EUR 970M
Net Income Growth	160.05%
Net Income Growth Q	98.68%
Net Income Growth Quarters	3%
Net Income Growth Years	1%
Net Income Growth5 Y	-3.97%
Pretax Margin	7.18%
Profit Margin	5.5%
Profit Per Employee	EUR 15,082
Profitable Years	1
ROA	3.48
Roa5y	1.36
ROCE	7.65
ROE	8.36
Roe5y	-1.95
ROIC	6.98
Roic5y	-5.23

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	3.31%
Cagr15y	4.07%
Cagr1y	13.77%
Cagr3y	13.06%
Cagr5y	-9.41%
Div CAGR10	1.59%
Div CAGR3	2.61%
Div CAGR5	1.56%
EPS Growth	152.5
EPS Growth Q	97.24
EPS Growth Quarters	2
EPS Growth Years	1
EPS Growth5 Y	-4.04
OCF Growth10 Y	4.6%
Revenue Growth	-1.88x
Revenue Growth Q	-4.69x
Revenue Growth Years	0x
Revenue Growth3 Y	-0.81x
Revenue Growth5 Y	-2.15x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.65
Assets	EUR 27.3B
Cash	EUR 2.6B
Current Assets	EUR 9.8B
Current Liabilities	EUR 7.4B
Debt	EUR 8.1B
Debt EBITDA	EUR 3.55
Debt Equity	EUR 0.71
Debt FCF	EUR 4.04
Equity	EUR 11.4B
Interest Coverage	5.58
Liabilities	EUR 15.8B
Long Term Assets	EUR 17.5B
Long Term Liabilities	EUR 8.4B
Net Cash	EUR -5.5B
Net Cash By Market Cap	EUR -25.01
Net Debt EBITDA	EUR 2.63
Net Debt Equity	EUR 0.48
Net Debt FCF	EUR 2.74
Tangible Book Value	EUR -904M
Tangible Book Value Per Share	EUR -0.95
WACC	7.5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.32
Inventory Turnover	3
Net Working Capital	EUR 967M
Quick ratio	0.79
Working Capital	EUR 2.4B
Working Capital Turnover	EUR 8.27

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.21%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	EUR 1.7
Dividend Years	2
Dividend Yield	7.21%
Ex Div Date	2026-05-14
Last Dividend	EUR 0.85
Payout Ratio	33.81%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	38.48%
1Y total return	13.76%
200-day SMA	24.08
3Y total return	44.51%
50-day SMA	24.18
50-day SMA vs 200-day SMA	50over200
5Y total return	-39%
All Time High	47.13
All Time High Change	-49.99%
All Time High Date	2021-04-12
All Time Low	9.8
All Time Low Change	140.51%
All Time Low Date	2009-03-30
ATR	0.58
Beta	0.92
Ch YTD	1.81
High	23.57
High52	27.57
High52 Date	2026-02-10
High52ch	-14.51%
Low	23.13
Low52	19.13
Low52 Date	2025-06-19
Low52ch	23.24%
Ma50ch	-2.53%
Price vs 200-day SMA	-2.1%
RSI	49.69
RSI Monthly	50.43
RSI Weekly	47.19
Sharpe ratio	0.42x
Sortino ratio	0.87
Total Return	5.01%
Tr YTD	1.81
Tr15y	81.87%
Tr1m	1.95%
Tr1w	4.15%
Tr3m	-5.07%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 1.5B
Operating Income Growth	-20.87
Operating Income Growth Q	55.48
Operating Income Growth5 Y	-3.58
Operating margin	8.6

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	950,696,984%
Net Borrowing	437,000,000
Shares Insiders	0.14%
Shares Institutions	63.7%
Shares Qo Q	0.27%
Shares Yo Y	2.21%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 1.9B
Average Volume	11,461x
Bv Per Share	11.97
CAPEX	EUR -287M
Ch10y	12.13
Ch15y	26.31
Ch1m	1.95
Ch1w	4.15
Ch1y	9.32
Ch3m	-5.07
Ch3y	32.27
Ch5y	-47.11
Ch6m	-2.68
Change	1.51%
Change From Open	1.51
Close	23.22
Days Gap	0
Depreciation Amortization	574,000,000
Dollar Volume	174,276.6
Earnings Date	2026-05-06
EBIT	EUR 1.5B
EBITDA	EUR 2.1B
EPS	EUR 1
F Score	7
FCF	EUR 2B
FCF EV Yield	7.28x
Financing CF	132,000,000
Fiscal Year End	December
Founded	1,891
Goodwill	9,611,000,000
Graham Number	16.90436
Graham Upside	-28.28
Income Tax	EUR 299M
Investing CF	-986,000,000
Is Primary Listing	0
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Date	2024-05-09
Last Split Type	Forward
Lynch Fair Value	EUR 5.19
Lynch Upside	-77.97
Ma150	24.31
Ma150ch	-3.04%
Ma20	23.72
Ma20ch	-0.64%
Net CF	1,399,000,000
Next Earnings Date	2026-07-28
Open	23.22
P FCF Ratio	10.97
P OCF Ratio	9.6
Payment Date	2026-05-29
Position In Range	100
Ppne	2,181,000,000
Price Date	2026-05-08
Price EBITDA	EUR 10.53
Relative Volume	0.66x
Revenue	17,642,000,000x
SBC By Revenue	0.7x
Share Based Comp	123,000,000
Tax By Revenue	1.69x
Tax Rate	23.6%
Tr6m	-2.68%
Volume	7,394
Z Score	1.95

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

ETR/PHI1 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+7.2%

$1.70 annual per share

Payout ratio

+33.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+1.6%

1 consecutive years of growth

Total shareholder yield

+5.0%

Next ex-dividend date: 2026-05-14

Performance

ETR/PHI1 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/PHI1?

Insider, institutional, and short-interest positioning.

Institutional ownership

+63.7%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+2.2%

Negative means the company is buying back shares.

Technical

ETR/PHI1 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.7

Neutral momentum band

Price vs 200-day MA

-2.1%

50/200-day relationship not available

Beta (5Y)

0.92

Moves roughly with the market

Sharpe ratio

0.42

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/PHI1

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/PHI1 stock rating?

etr/PHI1 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/PHI1 analysis?

The full report lives at /stocks/etr/PHI1/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/PHI1?

The latest report frames etr/PHI1 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/PHI1 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.